You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00084227 ↗	Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America	Completed	Pfizer	Phase 2/Phase 3	2004-07-01	The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
NCT00149383 ↗	Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria	Completed	McLaughlin-Rotman Center for Global Health, University of Toronto	Phase 1/Phase 2	2004-12-01	The purpose of this study is to examine the safety, tolerability, and efficacy of adjunctive rosiglitazone in the treatment of uncomplicated P.falciparum malaria.
NCT00149383 ↗	Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria	Completed	Mahidol University	Phase 1/Phase 2	2004-12-01	The purpose of this study is to examine the safety, tolerability, and efficacy of adjunctive rosiglitazone in the treatment of uncomplicated P.falciparum malaria.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Intervention	Trials
Malaria	12
Controlled Human Malaria Infection	2
Falciparum	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Intervention	Trials
Malaria	21
Malaria, Falciparum	7
Infections	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Location	Trials
Netherlands	6
Thailand	3
United States	3
Cambodia	2
Ethiopia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Location	Trials
Maryland	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	2
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	17
Terminated	3
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Sponsor	Trials
Radboud University	4
Medicines for Malaria Venture	3
The PATH Malaria Vaccine Initiative (MVI)	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Sponsor	Trials
Other	35
Industry	9
U.S. Fed	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.